We are live on
!
Find out more
CA
Cambridge Advisors Portfolio holdings
AUM
$582M
Turnover
4.86%
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
-12.32%
1 Year Est. Return
+19.14%
3 Year Est. Return
+52.94%
5 Year Est. Return
+51.55%
10 Year Est. Return
+171.25%
AUM
$366M
AUM Growth
-$53.7M
(-13%)
Cap. Flow
+$177K
Cap. Flow
% of AUM
0.05%
Top 10 Holdings %
Top 10 Hldgs %
55.1%
Holding
191
New
12
Increased
48
Reduced
94
Closed
14
Avg Time Held
4.7
years
Top 10 Avg Time Held
5.5
years
Top 20 Avg Time Held
5.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$1.92M |
| 2 |
First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF
FTRI
|
+$1.71M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$1.3M |
| 4 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$1.26M |
| 5 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$990K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.42M |
| 2 |
ARK Genomic Revolution ETF
ARKG
|
+$1.04M |
| 3 |
CERN
Cerner Corp
CERN
|
+$953K |
| 4 |
First Trust Smith Opportunistic Fixed Income ETF
FIXD
|
+$902K |
| 5 |
Vanguard Total International Bond ETF
BNDX
|
+$752K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 75.56% |
| 2 | Technology | 7.98% |
| 3 | Healthcare | 6.4% |
| 4 | Industrials | 2.64% |
| 5 | Financials | 2.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
3M
MMM
$85.3B
| $263K | 0.07% |
2,429
-60
| -2% | -$7.25K |
2014 Q4
30 quarters
|
|
152
Clorox
CLX
$10.4B
| $262K | 0.07% |
1,860
| – | – |
2014 Q4
30 quarters
|
|
153
Fidelity Dividend ETF for Rising Rates
FDRR
$761M
| $260K | 0.07% |
6,741
+40
| +0.6% | +$1.66K |
2019 Q2
12 quarters
|
|
154
Blackrock
BLK
$174B
| $259K | 0.07% |
426
-555
| -57% | -$361K |
2015 Q3
27 quarters
|
|
155
Invesco Active US Real Estate Fund
PSR
$55.9M
| $259K | 0.07% |
2,708
-30
| -1% | -$3.12K |
2020 Q3
7 quarters
|
|
156
Innovator Defined Wealth Shield ETF
BALT
$3.12B
| $258K | 0.07% |
+10,000
| New | +$257K |
2022 Q2
0 quarters
|
|
157
Charles River Laboratories
CRL
$14.6B
| $257K | 0.07% |
1,200
| – | – |
2017 Q2
20 quarters
|
|
158
CVS Health
CVS
$118B
| $240K | 0.07% |
2,592
-149
| -5% | -$14.5K |
2021 Q2
4 quarters
|
|
159
Sysco
SYY
$40.4B
| $239K | 0.07% |
2,825
-635
| -18% | -$53.2K |
2020 Q3
7 quarters
|
|
160
iShares Gold Trust
IAU
$61.9B
| $238K | 0.07% |
6,926
+220
| +3% | +$7.83K |
2014 Q4
30 quarters
|
|
161
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $237K | 0.06% |
6,430
+350
| +6% | +$13.9K |
2021 Q2
4 quarters
|
|
162
Innovator Growth-100 Power Buffer ETF October
NOCT
$275M
| $236K | 0.06% |
6,720
| – | – |
2020 Q4
6 quarters
|
|
163
Schwab US Large- Cap ETF
SCHX
$74.6B
| $226K | 0.06% |
15,189
+93
| +0.6% | +$1.51K |
2020 Q3
7 quarters
|
|
164
DELISTED
Cambria Cannabis ETF
TOKE
| $219K | 0.06% |
27,056
-3,881
| -13% | -$37.1K |
2019 Q4
10 quarters
|
|
165
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$511M
| $218K | 0.06% |
4,173
+370
| +10% | +$20.3K |
2021 Q4
2 quarters
|
|
166
Carrier Global
CARR
$45.3B
| $214K | 0.06% |
6,001
-74
| -1% | -$2.9K |
2020 Q4
6 quarters
|
|
167
Fortive
FTV
$17.5B
| $213K | 0.06% |
5,204
-713
| -12% | -$31.5K |
2016 Q3
23 quarters
|
|
168
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.92B
| $211K | 0.06% |
7,600
| – | – |
2020 Q2
8 quarters
|
|
169
Strategas Global Policy Opportunities ETF
SAGP
$76.8M
| $211K | 0.06% |
+9,293
| New | +$226K |
2022 Q2
0 quarters
|
|
170
Adobe
ADBE
$97.9B
| $205K | 0.06% |
560
-30
| -5% | -$12.2K |
2018 Q1
17 quarters
|
|
171
Innovator Power Buffer Step-Up Strategy ETF
PSTP
$134M
| $204K | 0.06% |
+8,400
| New | +$212K |
2022 Q2
0 quarters
|
|
172
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$289M
| $194K | 0.05% |
11,513
| – | – |
2017 Q1
21 quarters
|
|
173
First Trust SkyBridge Crypto Industry and Digital Economy ETF
CRPT
$109M
| $169K | 0.05% |
37,400
+16,000
| +75% | +$133K |
2021 Q4
2 quarters
|
|
174
DELISTED
Warner Bros
WBD
| $146K | 0.04% |
+10,891
| New | +$202K |
2022 Q2
0 quarters
|
|
|
RJA
175
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Agriculture Total Return
RJA
| $93K | 0.03% |
+10,000
| New | +$104K |
2022 Q2
0 quarters
|
|
Similar funds
MIP
LCM
1C
GFI
RIS
MCA
SC
FFG
Cambridge Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Cambridge Advisors held 191 positions worth $366M, down 13% from $420M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Cambridge Advisors's Q2 2022 filing shows 12 new, 48 increased, 94 reduced and 14 closed positions. Its largest new stake was First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF: 110,151 shares worth $1.47M. The largest sale was Vanguard Total Bond Market, an estimated $2.42M.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, up from 74% a quarter earlier, followed by Technology and Healthcare.
- Cambridge Advisors's largest Q2 2022 buy was First Trust Exchange-Traded Fund II First Trust Indxx Global Natural Resources Income ETF: 110,151 shares worth $1.47M.
- Cambridge Advisors added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $1.92M increase.
- Cambridge Advisors's biggest Q2 2022 reduction was Vanguard Total Bond Market, cutting an estimated $2.42M.
- Cambridge Advisors fully exited ARK Genomic Revolution ETF in Q2 2022, selling an estimated $1.04M.
- Cambridge Advisors's ten largest holdings make up 55% of its $366M portfolio in Q2 2022.
- Cambridge Advisors opened 12 new positions and closed 14 in Q2 2022.
- Cambridge Advisors's portfolio value fell 13% quarter-over-quarter to $366M.
Based on Cambridge Advisors's 13F filing for Q2 2022, filed 18 Jul 2022.